Your Cart ( 1 Item )

• The Efficacy and Safety of a New U.S. BotulinumToxin Type A in the Retreatment of Glabellar LinesFollowing Open-Label Treatment
  May 2009 | Volume 8 | Issue 5 | Original Article | 439 | Copyright © May 2009
  Mark G. Rubin MD, Jeffrey S. Dover MD FRCPC FRCP,Richard G. Glogau MD, David J. Goldberg MD JD, Mitchel P.Goldman MD, Joel Schlessinger MD FAAD FAACS
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs